Ziad2022-11-25T14:04:53-05:00During the event, more than 2 million alerts were sent to participants of the famous earthquake drill throughout the United States and Canada using multiple channels of communication. Read more >>
Ziad2022-11-25T14:04:53-05:00Wearable technologies such as exosuits can enhance people’s baseline abilities by giving them the ability to walk further or lift more than they would ordinarily be able to. In some cases, this means helping non-disabled people to carry out tasks more efficiently. Where it’s more profound, however, is in helping people with disabilities to perform actions that might otherwise be impossible.
This is where a powered brace called the MyoPro myoelectric arm orthosis excels. Manufactured by the wearable medical robotics company...
Ziad2022-11-25T14:04:53-05:00Putting together a sponsored content program is a time-consuming headache for buyers and publishers.
BrandVerge, a marketplace where buyers can browse publishers’ sponsored content options, aims to make it faster and easier to create sponsored content deals. The platform claims to shorten the deal-making process by an average of 67%. Read more >>
Ziad2022-11-25T14:04:54-05:00Corbus Pharmaceuticals Holdings, Inc., a clinical stage drug development company with the industry’s leading pipeline focused on treating inflammatory and fibrotic diseases by targeting the endocannabinoid system, today announced continued favorable safety and tolerability profiles and further improvement in efficacy outcomes in open-label extensions (OLEs) of lenabasum Phase 2 studies in two rare and serious autoimmune diseases, systemic sclerosis (SSc) and dermatomyositis (DM). Read more >>
Ziad2022-11-25T14:04:54-05:00Corbus Pharmaceuticals has received a patent from the U.S. Patent and Trademark Office covering all compositions that comprise lenabasum and might be used to treat any fibrotic disease, including cystic fibrosis (CF), the company announced in a press release. Read more >>
Ziad2022-11-25T14:04:54-05:00Product development going wrong? You may need a tiger team.
By Jeff Champagne and Eric Claude, MPR Associates, Inc.
We would all like for product development projects to go smoothly and predictably, but you know what they say about “the best-laid plans.” Robert Burns aside, when needed technologies do not integrate as easily as planned, hardware or software bugs crop up at the last minute (or worse, cause failures in the field), or project teams struggle to complete work on schedule, forward...
Ziad2022-11-25T14:04:54-05:00Smart Health Innovation Lab, a market adoption accelerator for healthcare technologies, today announced the graduation of two companies — Emovi and NeuroFlow – from its Smart Health Certification Program’s inaugural class of 2018. Read more >>
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.